ONGLYZA
Live / Registered — Registered and renewed (as of 15 Jul 2019)
What this means for you
Registered since 08 Dec 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Dec 2019).
Record
- Serial number
- 78791308
- Registration number
- 3723838
- Mark type
- Stylized text
- Filed
- 13 Jan 2006
- Published for opposition
- 13 Mar 2007
- Registered
- 08 Dec 2009
- Next maintenance due
- 08 Dec 2019
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment and prevention of diabetes
Owner
- ASTRAZENECA AB, Södertälje, SE
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 22 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 22 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Jul 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 15 Jul 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 15 Jul 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Jul 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jun 2019 — TEAS SECTION 8 & 9 RECEIVED
- 08 Dec 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Aug 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Aug 2015 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Aug 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL